April 4, 2025
In women with signs of ischemia but no obstructive coronary artery disease (OCAD), intensive medical therapy did not reduce the first occurrence of a major cardiovascular […]
April 3, 2025
CHICAGO — For older patients at high risk for a heart failure event who are scheduled for transcatheter aortic valve implantation (TAVI), dapagliflozin, a sodium glucose […]
April 2, 2025
CHICAGO — Five years after treatment, patients with severe aortic stenosis had comparable rates of all-cause mortality or disabling stroke, whether they received transcatheter aortic valve […]
April 1, 2025
TOPLINE: Early introduction of atorvastatin vs placebo in patients with hypertension demonstrated significant benefits in reducing cardiovascular disease events, such as non-fatal myocardial infarction (MI) and […]
April 1, 2025
Patients with heart failure and iron deficiency treated with intravenous iron had lower rates of cardiovascular death or hospitalization for heart failure, but results of the […]
April 1, 2025
Blood oxygen measurements taken with pulse oximeters in hospitals tend to be lower than they really are, according to the Equiox study, which was designed to […]
March 31, 2025
People at risk of a cardiac event after a percutaneous coronary intervention (PCI) stent procedure who received long-term antiplatelet therapy with clopidogrel were 29% less likely […]
March 30, 2025
CHICAGO — Patients with severe triple-vessel heart disease who underwent a less-invasive stent procedure fared just as well as those who underwent open-heart bypass surgery after […]
March 30, 2025
CHICAGO — Extended therapy with reduced-dose apixaban is just as effective as the high dose in preventing recurrent venous thromboembolism (VTE) in patients with active cancer […]